Efficacy Study on Trabectedin in Retroperitoneal Leiomyosarcoma and Well Differentiated/Dedifferentiated Liposarcoma

NCT02247544 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

105

Enrollment

NETWORK

Sponsor class

Conditions

Liposarcoma
Leiomyosarcoma

Interventions

DRUG: Trabectedin

Sponsor

Italian Sarcoma Group

Collaborators

[object Object]